iRadimed/$IRMD
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About iRadimed
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.
Ticker
$IRMD
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
160
ISIN
US46266A1097
Website
iRadimed Metrics
BasicAdvanced
$665M
33.73
$1.55
0.92
$0.62
1.30%
Price and volume
Market cap
$665M
Beta
0.92
52-week high
$63.29
52-week low
$41.69
Average daily volume
32K
Dividend rate
$0.62
Financial strength
Current ratio
8.867
Quick ratio
5.94
Total debt to equity
0.066
Dividend payout ratio (TTM)
39.74%
Management effectiveness
Return on assets (TTM)
14.92%
Return on equity (TTM)
23.81%
Valuation
Price to earnings (TTM)
33.734
Price to revenue (TTM)
8.823
Price to book
7.38
Price to tangible book (TTM)
7.66
Price to free cash flow (TTM)
48.125
Dividend yield (TTM)
1.19%
Forward dividend yield
1.30%
Growth
Revenue change (TTM)
11.04%
Earnings per share change (TTM)
10.72%
3-year revenue growth (CAGR)
18.73%
3-year earnings per share growth (CAGR)
23.17%
What the Analysts think about iRadimed
Analyst ratings (Buy, Hold, Sell) for iRadimed stock.
iRadimed Financial Performance
Revenues and expenses
iRadimed Earnings Performance
Company profitability
iRadimed News
AllArticlesVideos
IRADIMED CORPORATION (IRMD) Q1 2025 Earnings Call Transcript
Seeking Alpha·3 weeks ago
IRADIMED CORPORATION Announces First Quarter 2025 Financial Results
GlobeNewsWire·3 weeks ago
CORRECTION -- IRADIMED CORPORATION to Hold First Quarter of 2025 Financial Results Conference Call on May 5, 2025
GlobeNewsWire·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
May30
iRadimed
Dividend·Payment
$0.17Per share
FAQs
What’s the current market cap for iRadimed stock?
iRadimed (IRMD) has a market cap of $665M as of May 23, 2025.
What is the P/E ratio for iRadimed stock?
The price to earnings (P/E) ratio for iRadimed (IRMD) stock is 33.73 as of May 23, 2025.
Does iRadimed stock pay dividends?
Yes, the iRadimed (IRMD) stock pays dividends to shareholders. As of May 23, 2025, the dividend rate is $0.62 and the yield is 1.3%. iRadimed has a payout ratio of 39.74% on a trailing twelve-month basis.
When is the next iRadimed dividend payment date?
The next iRadimed (IRMD) dividend payment is scheduled for May 30, 2025.
What is the beta indicator for iRadimed?
iRadimed (IRMD) has a beta rating of 0.92. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.